⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
XENE News
Xenon Pharmaceuticals Inc
Xenon Announces Investor Webinar Highlighting Azetukalner and Epilepsy Data from AES 2025
globenewswire.com
XENE
Xenon to Present New Azetukalner OLE Study Data in Epilepsy at AES 2025
globenewswire.com
XENE
Xenon to Present at Upcoming Investor Conferences
globenewswire.com
XENE
Xenon Reports Third Quarter 2025 Financial Results & Business Update
globenewswire.com
XENE
Xenon to Report Q3 2025 Financial Results on November 3, 2025
globenewswire.com
XENE
Xenon Announces Appointment of Tucker Kelly as Chief Financial Officer
globenewswire.com
XENE
Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
globenewswire.com
XENE
Xenon Announces Upcoming Investor Webinar to Discuss Early-Stage Ion Channel Programs for the Potential Treatment of Pain
globenewswire.com
XENE